| Overriding the Jehovah's Witness patient's refusal of blood: a reply to Cahana, Weibel, and Hurst. | |
| | |
MedLine Citation:
|
PMID: 19594850 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This article is a response to a survey on moral reasoning among Swiss health professionals that appeared in a recent issue of this journal. The authors of that survey inquired whether or not their respondents would give a blood transfusion to a Jehovah's Witness patient who clearly refused it. A substantial number of the respondents answered that they would override the patient's refusal and give the transfusion. The present article examines the two ethical rationales that were offered to explain the overriding respondents' answers and argues that neither one is ethically acceptable. It concludes with an account of the phenomenon of "motivated reasoning" that, so it is argued, better explains why the overriders would refuse to honor the Jehovah's Witness patient's transfusion refusal. |
| | |
Authors:
|
John D Banja |
Publication Detail:
|
Type: Journal Article Date: 2009-07-06 |
Journal Detail:
|
Title: Pain medicine (Malden, Mass.) Volume: 10 ISSN: 1526-4637 ISO Abbreviation: Pain Med Publication Date: 2009 Jul-Aug |
Date Detail:
|
Created Date: 2009-08-17 Completed Date: 2009-11-02 Revised Date: 2011-12-28 |
Medline Journal Info:
|
Nlm Unique ID: 100894201 Medline TA: Pain Med Country: United States |
Other Details:
|
Languages: eng Pagination: 878-82 Citation Subset: IM |
Affiliation:
|
Department of Rehabilitation Medicine, Emory University, Atlanta, Georgia 30322, USA. jbanja@emory.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Transfusion
/
ethics* Death Health Care Surveys Humans Informed Consent Jehovah's Witnesses* Switzerland |
| Comments/Corrections | |
Comment In:
|
Pain Med. 2011 Nov;12(11):1684-8
[PMID:
22099063
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Age-related patterns in adaptation to cancer pain: a mixed-method study.
Next Document: Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.